Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells.
about
Identification of TMEM208 and PQLC2 as reference genes for normalizing mRNA expression in colorectal cancer treated with aspirin.The Influence of BRAF and KRAS Mutation Status on the Association between Aspirin Use and Survival after Colon Cancer Diagnosis.Cancer and Thrombosis: The Platelet Perspective.Important molecular genetic markers of colorectal cancer.Platelet-targeted pharmacologic treatments as anti-cancer therapy.MOLECULAR PATHWAYS: TARGETING THE MICROENVIRONMENT OF LIVER METASTASES.Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer.Platelets as crucial partners for tumor metastasis: from mechanistic aspects to pharmacological targeting.Platelets, circulating tumor cells, and the circulome.Targeting Platelets for the Treatment of Cancer.Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention.Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past?Inhibition of the Biosynthesis of Prostaglandin E2 By Low-Dose Aspirin: Implications for Adenocarcinoma MetastasisThe Role of Platelet-Derived ADP and ATP in Promoting Pancreatic Cancer Cell Survival and Gemcitabine Resistance.Cancer and Thrombotic Risk: The Platelet Paradigm.MicroRNA-370 inhibits the growth and metastasis of lung cancer by down-regulating epidermal growth factor receptor expression.Motivation for Launching a Cancer Metastasis Inhibition (CMI) Program.Protein levels of clusterin and glutathione synthetase in platelets allow for early detection of colorectal cancer.Unlocking Aspirin's Chemopreventive Activity: Role of Irreversibly Inhibiting Platelet Cyclooxygenase-1.Ticagrelor inhibits platelet-tumor cell interactions and metastasis in human and murine breast cancer.P2Y12 Receptors in Tumorigenesis and Metastasis.Human Cancer and Platelet Interaction, a Potential Therapeutic Target.Platelet Metabolism and Other Targeted Drugs; Potential Impact on Immunotherapy.Aspirin Prevention of Colorectal Cancer: Focus on NF-κB Signalling and the Nucleolus.
P2860
Q33618460-3FADC227-B323-42DE-BB09-2BEEDB08942AQ36261529-37507AF3-E9CB-44EC-899B-EB2488FE64CDQ37558436-1697D38E-E9FB-4EBE-97B9-099C6FFF21E0Q37619856-502A5838-4B8F-491C-95F8-99D790C5106FQ38657846-777A6765-55DB-42D2-ACE9-7CF51490893FQ38671001-D3750E02-95FA-4DE5-BD34-8C30D6839895Q39112764-F6E132A2-2698-42E8-92C0-403F288452E1Q39294808-FF7C69C5-4D4B-477E-8569-2FE15CE5B78CQ39408199-42A846BA-E3B5-493D-836D-5A86F2D2AE74Q39454244-1F132EE3-F697-4BBB-B8A3-05DF7DFE89EEQ40100113-7C4FBAFF-B0A1-4DF0-9B57-A21C2ADA7267Q41420993-81FEB455-92B8-4A66-AF9A-6A3D816CE02EQ42731074-44321510-04D3-4481-94C2-BCA5FF915C1AQ42991719-349E7595-9785-41A3-BD6A-31E0FCAC0FA5Q44264785-AF389D23-9C9A-44A2-8304-FAAE75E00E81Q45833730-EC2E78DE-1B9C-42E0-8143-46CF94394251Q47270653-D6746CAC-828C-4B83-80A5-717A39E5D7B0Q47890629-5F77F6E3-4356-4F6F-ADD7-95F7D9D62BE0Q48009155-0AA93ADC-C5B5-4A56-8528-1CF41E4ADDF9Q48265369-5046A8EA-8096-4046-AB62-0B5F38A2A2E5Q49884998-0710BFE2-2C2C-4F97-839B-02858EAC2786Q52717949-FE9FCBAE-0005-42BF-BADC-8D4FEE23C49EQ55398181-55B6B724-30D9-4001-BF92-73E6E2798E6AQ55439392-013DF1A8-9E7D-416D-B093-2AA1120F710B
P2860
Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Aspirin prevents colorectal ca ...... een platelets and tumor cells.
@en
type
label
Aspirin prevents colorectal ca ...... een platelets and tumor cells.
@en
prefLabel
Aspirin prevents colorectal ca ...... een platelets and tumor cells.
@en
P2093
P2860
P50
P356
P1433
P1476
Aspirin prevents colorectal ca ...... een platelets and tumor cells.
@en
P2093
Angela Sacco
Annalisa Bruno
Carlo Patrono
Emanuela Ricciotti
Garret A FitzGerald
Mariangela Cirillo
Paola Patrignani
Rosalia Grande
Sara Alberti
Valerio Cufino
P2860
P304
32462-32477
P356
10.18632/ONCOTARGET.8655
P407
P577
2016-04-08T00:00:00Z